Evidence map›Paper›PMID 36743028›Full record

ArticleACS omega2023

DNA Nano Trihedron Exhibits an Inhibitory Effect on Breast Cancer Cells.

Yu Wang, Shuting Chen, Jingyi Zhang, Qing Ye, Yin Liu

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu WangSchool of Medicine, Nankai University, Tianjin 300071, P. R. China.
Shuting ChenSchool of Medicine, Nankai University, Tianjin 300071, P. R. China.
Jingyi ZhangSchool of Medicine, Nankai University, Tianjin 300071, P. R. China.
Qing YeKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, School of Physics and TEDA Applied Physics, Nankai University, Tianjin 300071, P. R. China.ORCID https://orcid.org/0000-0002-1203-6540
Yin LiuSchool of Medicine, Nankai University, Tianjin 300071, P. R. China.ORCID https://orcid.org/0000-0001-7379-5885

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a new type of nanomaterial, DNA nanomaterials show great potential in biomedical applications because of their high precision, high controllability, and high biocompatibility among other characteristics. Therapeutic drugs based on DNA nanomaterials have been shown to have beneficial therapeutic effects on a variety of diseases. The application of DNA nanomedicines in the treatment of diseases has become a rapidly developing area of study. However, the instability of DNA nanomaterials greatly limits their clinical application. Therefore, we designed and synthesized a stable topological DNA nanostructure: DNA Nano Trihedron (DNT). We demonstrated that DNT could enter MCF-7 cells without the transfection agent. In addition, DNT could induce dramatic changes in gene expression and produce significant inhibitory effects on MCF-7 cells. DNT after two months of storage still had an inhibitory effect on MCF-7 cells.

Identifiers

PMID36743028
PMCPMC9893459

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.